Nephrol Dial Transplant (2002) 17: 1758-1765
© 2002 European Renal Association-European Dialysis and Transplant Association
Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics
Department of Medicine IV/4/Nephrology, University of Erlangen-Nürnberg, Germany
Background. Hypercholesterolaemia has been found to impair endothelial function in the systemic and coronary circulations and lipid-lowering therapy with statins has been shown to improve this abnormality.
Methods. We examined the impact of hypercholesterolaemia on L-arginine-induced renal vascular relaxation by a cross-sectional study, and the effects of lipid-lowering therapy by a double-blind, randomized, placebo-controlled study. Using constant infusion input clearance technique (PAH and inulin respectively), changes of renal plasma flow (RPF) and glomerular filtration rate (GFR) in response to intravenous infusions of L-arginine (100 mg/kg/30 min and 500 mg/kg/30 min) were studied in 21 hypercholesterolaemic humans (age 57±9 years, LDL-cholesterol 211±35 mg/dl) and in 20 young healthy (age 26±2 years, LDL-cholesterol 90±27 mg/dl) and 20 older healthy age-matched control individuals (age 50±8 years, LDL-cholesterol 106±20 mg/dl). In addition, changes of blood pressure, heart rate, urinary excretion of sodium, and cyclic guanosine monophosphate were measured. Patients were analysed before and after 3 months treatment with either fluvastatin (40 mg twice daily, n=11) or placebo (n=10).
Results. In hypercholesterolaemic patients, L-arginine increased RPF and GFR (P<0.01) and urinary excretion of sodium (P<0.05) in a dose-dependent manner. Interestingly, changes were similar between the hypercholesterolaemic patients and the young and the age-matched control individuals (
RPF 100 mg/kg/30 min, 40±51 ml/min vs 40±52 ml/min, P=NS; RPF 500 mg/kg/30 min, 114±85 ml/min vs 130±78 ml/min, P=NS). L-arginine significantly lowered systemic arterial pressure and increased heart rate in all groups. Despite significant reductions in LDL-cholesterol levels (291±35 mg/dl vs 213±30 mg/dl, P<0.001), treatment with fluvastatin did not alter the renal haemodynamic response pattern to L-arginine infusion when compared to baseline values and to those with placebo.
Conclusion. In contrast to studies performed in the vasculature of the human forearm or the coronary circulation, our results suggest that hypercholesterolaemia is not associated with an impaired L-arginine-induced renal vascular relaxation.
Keywords: hypercholesterolaemia; L-arginine; nitric oxide; renal haemodynamics
Correspondence and offprint requests to: Prof. Dr Roland E. Schmieder, Medizinische Klinik IV/4, University of Erlangen-Nürnberg, Breslauer Str. 201, D-90471 Nürnberg, Germany. Email: roland.schmieder{at}rzmail.uni\|[hyphen]\|erlangen.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Strazzullo, S. M. Kerry, A. Barbato, M. Versiero, L. D'Elia, and F. P. Cappuccio Do Statins Reduce Blood Pressure?: A Meta-Analysis of Randomized, Controlled Trials Hypertension, April 1, 2007; 49(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Delles, M. P. Schneider, S. Oehmer, E. H. Fleischmann, and R. E. Schmieder L-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes Diabetes Care, June 1, 2003; 26(6): 1836 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zitta, H. Holzer, W. Estelberger, and G. Reibnegger Assessment of experimentally induced acute changes of renal haemodynamics Nephrol. Dial. Transplant., May 1, 2003; 18(5): 1030 - 1030. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Fleischmann and R. E. Schmieder Reply Nephrol. Dial. Transplant., May 1, 2003; 18(5): 1030 - 1031. [Full Text] [PDF]
|
|